Nanoparticle Formulation Market Professional Survey Report By 2035

By Author: kylie
Total Articles: 81
Comment this article

Key Market Insights
 Presently, more than 100 nanoparticle formulation technologies are being offered by companies across the globe in order to augment the development and manufacturing of nanoparticle-based drugs
 Close to 80% technologies are designed for the formulation of organic nanoparticles; of these, nearly 50% are intended for drug delivery via injectable route, primarily targeting oncological disorders
 In pursuit of gaining a competitive edge, industry stakeholders are actively innovating and inventing new nanoparticle formulations technologies that can be utilized across a wide range of therapeutic areas
 The current service providers landscape has over 80 companies offering a wide range of nanoparticle formulation services at various scales of operation
 The market landscape features the presence of both well-established players and new entrants with the requisite expertise to develop / manufacture nanoparticle-based drugs for an extensive range of application areas
 Owing to the rise in demand for nanoparticle-based formulations, service providers are continuously ...
... expanding their existing capabilities to enhance their respective service portfolios
 A steady growth in the partnership activity has been observed in recent years; R&D agreements have been the most prominent type of partnership model adopted by players based in the US
 More than 1,700 patents related to nanoparticle formulation and development have been filed by / granted to various organizations in order to protect the intellectual property
 Researchers and industry players have been actively engaged in developing efficacious nanoparticle-based drugs; our proprietary evaluation framework allows a detailed assessment of various types of nanoparticles across key parameters
 The nanoparticle formulation service market is likely to grow at a CAGR of ~9% over the next decade, driven by revenues generated from commercial scale of operation

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Nanoparticles
3.3. Classification of Nanoparticles
3.4. Methods of Nanoparticle Formulation
3.5. Applications of Nanoparticle-based Systems
3.6. Challenges Associated with Nanoparticle Formulation
3.7. Need for Outsourcing Nanoparticle Formulation
3.8 Concluding Remarks

4. TECHNOLOGY LANDSCAPE
4.1. Chapter Overview
4.2. Nanoparticle Formulation: Technology Landscape
4.3. Nanoparticle Formulation: Technology Developer Landscape

5. SERVICE PROVIDERS LANDSCAPE
5.1. Chapter Overview
5.2. Nanoparticle Formulation: Service Providers Landscape

6. TECHNOLOGY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Assumptions / Key Parameters
6.3. Methodology
6.4. Technology Competitiveness Analysis

7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions / Key Parameters
7.3. Methodology
7.4. Company Competitiveness Analysis

8. COMPANY PROFILES
8.1. Chapter Overview
8.2. Ascension Sciences
8.2.1. Company Overview
8.2.2. Technology Portfolio
8.2.3. Service Portfolio
8.2.4. Recent Developments and Future Outlook

8.3. DIANT Pharma
8.4. ExonanoRNA
8.5. Nanoform
8.6. NanoVation Therapeutics
8.7. NanoVelos
8.8. NTT Biopharma
8.9. Organoid-X BioTech
8.10. Vaxinano

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Nanoparticle Formulation Technologies and Services: Partnerships and Collaborations

10. PATENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Nanoparticle Formulation Domain: Patent Analysis
10.4. Patent Benchmark Analysis
10.5. Patent Valuation Analysis

11. NANOPARTCLE EVALUATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Organic Nanoparticles
11.4. Inorganic Nanoparticles
11.5. Carbon-based Nanoparticles

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Global Nanoparticle Formulation Services Market, 2023-2035
12.4. Nanoparticle Formulation Services Market: Analysis by Type of Nanoparticle Formulated
12.5. Nanoparticle Formulation Services Market: Analysis by Scale of Operation
12.6. Nanoparticle Formulation Services Market: Analysis by Key Geographical Regions

13. CASE STUDY: TECHNOLOGY LICENSING DEALS
13.1. Chapter Overview
13.2. Recent Technology Licensing Deals
13.3. Concluding Remarks

14. CONCLUSION

15. EXECUTIVE INSIGHTS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/nanoparticle-formulation-market.html

Learn from experts: do you know about these emerging industry trends?
Patient Recruitment – Key Determinant of Successful Clinical Trials
Exploring AI-based Digital Pathology

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com